Viewing Study NCT01792518


Ignite Creation Date: 2025-12-25 @ 4:33 AM
Ignite Modification Date: 2026-02-21 @ 2:51 PM
Study NCT ID: NCT01792518
Status: COMPLETED
Last Update Posted: 2017-03-06
First Post: 2013-02-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin
Sponsor: Boehringer Ingelheim
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 1218.89
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View